RO7204239
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for RO7204239, covering 2026-02-12 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity [Phase 1]